The time to build a giant vaccine factory is now
The latest data on the Omicron variant is very troubling. As the Financial Times' John Burn-Murdoch points out, it's creating a wave of infections in South Africa that thus far is moving even faster than the Delta variant. It's already been detected in multiple American states, and given poor U.S. surveillance of infection, it's probably all over the place already. It also seems that the immunity created by a prior infection is less good against Omicron, which may imply the American South is in for another devastating wave soon.
So long as millions and millions of people around the world are unvaccinated, above all in Africa, this could keep happening over and over. As Edward Luce points out (also at FT), the U.S. has pledged some two billion doses of vaccines to poorer countries, but so far has delivered only about 111 million. Only about 5 percent of Africans are vaccinated, which raises the risk of even worse variants coming after Omicron.
What the world needs is a giant excess of vaccines. Rich countries are always going to prioritize their own citizens, for good reasons or bad. We need so much that every single country can have a big surplus, and then some — so the more difficult bottlenecks in administration and hesitancy can be addressed.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Uncle Sam could have made this happen. Back in May, I pointed out that a large, state-owned vaccine factory that could churn out on the order of 15 billion doses of the mRNA shots (which are easier to manufacture en masse for technical reasons) per year would cost only about $4 billion — a microscopic pittance compared to the $5 trillion or so America has spent on pandemic relief measures. If we'd done it then, the first doses would be coming out about now.
The best time to start building such a factory would have been a year ago, but the second-best time would be right now. We may need Omicron-specific boosters, or other ones after that. And who knows what pandemics might be in store for the future? Let's make sure for the next one humanity isn't caught flat-footed.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Ryan Cooper is a national correspondent at TheWeek.com. His work has appeared in the Washington Monthly, The New Republic, and the Washington Post.
-
'Republicans want to silence Israel's opponents'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Poland, Germany nab alleged anti-Ukraine spies
Speed Read A man was arrested over a supposed Russian plot to kill Ukrainian President Zelenskyy
By Peter Weber, The Week US Published
-
Today's political cartoons - April 19, 2024
Cartoons Friday's cartoons - priority delivery, USPS on fire, and more
By The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published